Description
Vestibular Schwannomas covers multiple facets of vestibular schwannomas, including advancements in surgical techniques, radiological innovations, long-term patient outcomes, and implications for hearing preservation. It serves as a comprehensive guide for clinicians and researchers aiming to enhance diagnostic accuracy and therapeutic strategies in managing these complex tumors which are benign, slow-growing tumors that originate from the Schwann cells that line the vestibular nerve. They are the most prevalent neoplasms found in the cerebellopontine angle (CPA), the critical junction between the cerebellum and the brainstem.Their incidence, clinical presentation, and impact on surrounding neurological structures make them a focal point of research and medical intervention. Understanding their etiology, diagnosis, and treatment options requires an interdisciplinary approach bridging neurology, otology, and radiology.- Consolidates best practices on the diagnosis and treatment of vestibular schwannomas- Includes both sporadic and neurofibromatosis type 2 vestibular schwannomas- Covers stereotaxic radiosurgery and microsurgical resection- Discusses molecular biology, histopathology, and genomics- Presents rehabilitation for neurological deficits resulting from schwannomas and treatment
Table of Contents
1. History of vestibular schwannoma managementSection I. Basic Science 2. Applied anatomy in vestibular schwannoma3. Molecular biology and disease models of vestibular schwannomas: State of the art4. Pathology and tumor microenvironment of vestibular schwannoma5. Genomics of vestibular schwannoma6. Vestibular schwannomas: Key research questions and prioritiesSection II. Assessment 7. Clinical evaluation and investigation of patients with a sporadic vestibular schwannoma8. Clinical evaluation and investigation of vestibular schwannoma in NF2-related schwannomatosis9. Vestibular schwannoma imaging and differential diagnosis10. Clinical epidemiology of sporadic vestibular schwannomas11. Clinical epidemiology of NF2-related schwannomatosisSection III. Treatment 12. Surveillance management of vestibular schwannoma: present and future strategies13. Medical therapy for vestibular schwannomas14. Translabyrinthine approach to the cerebellopontine angle15. Retrosigmoid approach to vestibular schwannoma16. Middle fossa approach to vestibular schwannomas17. The retrolabyrinthine approach18. Endoscopic vestibular schwannoma surgery19. Vestibular schwannoma microsurgical technique20. Outcomes following vestibular schwannoma surgery21. Salvage resection and radiosurgery following failed primary treatment of vestibular schwannomas22. Hearing preservation surgery for vestibular schwannoma23. Vestibular schwannoma, postsurgical complications24. Anesthesia for excision of vestibular schwannomaSection IV. Stereotactic radiosurgery for vestibular schwannomas 25. Gamma knife radiosurgery for vestibular schwannomas26. LINAC stereotactic radiosurgery for vestibular schwannomas27. Fractionated radiotherapy for vestibular schwannoma28. Proton therapy for vestibular schwannomasSection V. General Considerations 29. Decision making in sporadic VS30. Decision making in NF2-related schwannomatosis31. Management of vestibular schwannoma in the elderly32. Subtotal versus total excision of vestibular schwannomas33. Quality of life after treatment of vestibular schwannomas34. The role of the clinical nurse specialist in managing vestibular schwannoma35. Vestibular schwannoma: Global perspectivesSection VI. Rehabilitation 36. Secondary trigeminal neuralgia due to vestibular schwannoma37. Hearing rehabilitation in patients with vestibular schwannomas38. Prevention and rehabilitation of facial palsy in patients with vestibular schwannomas39. Dizziness in vestibular schwannomas40. Tinnitus and its management in patients with vestibular schwannoma
